@FuturesFarming Notes Passed Bulenox Evaluations in Multi-Firm X Post

On Tuesday, January 27, the X account @FuturesFarming published a trading recap that included a brief but explicit line: "Passed some bulenox evals." The mention placed Bulenox within a broader account of the trader's activity across several futures prop firms.

The Bulenox reference appears in a longer post on X that catalogs the trader's day across multiple platforms. Alongside the Bulenox note, @FuturesFarming reported a $25,000 trading day on Tradeify, a $7,300 payout request that pushed their cumulative withdrawals from that account past $100,000, and progress on evaluations at Take Profit Trader, TradeDay, and FundedNext. The Bulenox line itself is short and unadorned, stating only that the trader passed some of the firm's evaluations.

What the post documents about Bulenox is narrow. It confirms that the trader states they cleared one or more Bulenox evaluation accounts as of that date. It does not identify which account size or sizes were used, which instruments were traded to reach the profit target, how long the evaluations took, or whether the trader has since moved to a funded stage or requested a payout from Bulenox. No screenshot or dashboard image tied specifically to Bulenox was included in the post.

“Passed some bulenox evals.”— @FuturesFarming on X, January 27

The context around the mention is worth noting for readers weighing credibility. The same post details a $10,000 milestone bonus at Tradeify for crossing $100,000 in cumulative payouts, a $5,000 weekly bonus, and a blown evaluation at FundedNext that the trader attributes to not moving a stop into profit. That mix of wins and losses, disclosed in the same breath, is the kind of detail that tends to accompany genuine trader recaps rather than promotional copy.

For prospective Bulenox customers, the useful signal here is limited but real. A trader active enough to be juggling accounts at six firms simultaneously reports clearing Bulenox's evaluation gate. The post does not establish a Bulenox payout, and readers should not read it as one. It is a data point on evaluation pass-through, nothing more, and the trader offered no commentary on Bulenox's rules, platform, or payout process.